Tarsus Pharmaceuticals Inc
NASDAQ:TARS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Tarsus Pharmaceuticals Inc
NASDAQ:TARS
|
US |
|
TNG Ltd
ASX:TNG
|
AU |
|
Walt Disney Co
NYSE:DIS
|
US |
|
Jupiter Wagons Ltd
NSE:JWL
|
IN |
|
Savills PLC
LSE:SVS
|
UK |
|
Philip Morris International Inc
NYSE:PM
|
US |
|
Apogee Enterprises Inc
NASDAQ:APOG
|
US |
|
Digi Power X Inc
NASDAQ:DGXX
|
CA |
|
S
|
SeaStar Medical Holding Corp
NASDAQ:ICU
|
US |
|
I
|
International Consolidated Airlines Group SA
OTC:ICAGY
|
UK |
|
Storebrand ASA
OSE:STB
|
NO |
|
STMicroelectronics NV
MIL:STMMI
|
NL |
|
Pieris Pharmaceuticals Inc
NASDAQ:PIRS
|
US |
|
Virgin Galactic Holdings Inc
NYSE:SPCE
|
US |
|
Aero Energy Ltd
F:J5B
|
CA |
|
Telo Genomics Corp
XTSX:TELO
|
CA |
|
Technip Energies NV
PAR:TE
|
FR |
|
Inseego Corp
NASDAQ:INSG
|
US |
|
Mhp Se
LSE:MHPC
|
UA |
|
Premier Foods PLC
LSE:PFD
|
UK |
|
Pc Partner Group Ltd
HKEX:1263
|
HK |
|
Uni-Select Inc
TSX:UNS
|
CA |
|
Naver Corp
KRX:035420
|
KR |
|
W
|
Whirlpool Corp
SWB:WHR
|
US |
Wall St Price Targets
TARS Price Targets Summary
Tarsus Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
TARS is 95.37 USD with a low forecast of 88.88 USD and a high forecast of 105 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TARS's stock price target?
Price Target
95.37
USD
According to Wall Street analysts, the average 1-year price target for
TARS is 95.37 USD with a low forecast of 88.88 USD and a high forecast of 105 USD.
What is the Revenue forecast for Tarsus Pharmaceuticals Inc?
Projected CAGR
19%
The compound annual growth rate for Revenue over the next 8 years is 19%.